Mill Road Capital Management LLC Buys Shares of 100,453 ZimVie Inc. (NASDAQ:ZIMV)

Mill Road Capital Management LLC purchased a new position in ZimVie Inc. (NASDAQ:ZIMV - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 100,453 shares of the company's stock, valued at approximately $1,401,000. ZimVie accounts for about 0.7% of Mill Road Capital Management LLC's investment portfolio, making the stock its 21st largest position. Mill Road Capital Management LLC owned 0.36% of ZimVie at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ZIMV. Barclays PLC grew its stake in ZimVie by 338.4% in the third quarter. Barclays PLC now owns 43,437 shares of the company's stock worth $690,000 after purchasing an additional 33,529 shares during the period. Geode Capital Management LLC grew its stake in shares of ZimVie by 2.4% in the third quarter. Geode Capital Management LLC now owns 646,564 shares of the company's stock worth $10,263,000 after acquiring an additional 15,053 shares during the last quarter. Principal Financial Group Inc. purchased a new stake in shares of ZimVie in the third quarter worth $275,000. JPMorgan Chase & Co. grew its stake in shares of ZimVie by 66.7% in the third quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company's stock worth $2,911,000 after acquiring an additional 73,395 shares during the last quarter. Finally, Monarch Capital Management Inc. grew its stake in shares of ZimVie by 6.2% in the fourth quarter. Monarch Capital Management Inc. now owns 65,560 shares of the company's stock worth $915,000 after acquiring an additional 3,847 shares during the last quarter. 95.63% of the stock is owned by hedge funds and other institutional investors.

ZimVie Stock Performance

Shares of NASDAQ:ZIMV traded up $0.14 during midday trading on Tuesday, reaching $9.45. 38,304 shares of the company's stock traded hands, compared to its average volume of 221,242. The company has a market cap of $263.01 million, a price-to-earnings ratio of -0.72 and a beta of 2.14. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. ZimVie Inc. has a one year low of $8.56 and a one year high of $22.40. The stock has a 50 day moving average of $11.08 and a 200 day moving average of $12.99.

ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.02. The firm had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. As a group, equities research analysts anticipate that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th. B. Riley assumed coverage on ZimVie in a research note on Thursday, April 10th. They issued a "buy" rating and a $16.00 target price on the stock.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.